By Counterforce Health Team in Myozyme (alglucosidase alfa) —

How to Get Myozyme (Alglucosidase Alfa) Covered by Blue Cross Blue Shield in Pennsylvania: Forms, Appeals, and Success Strategies

Answer Box: Your Path to Coverage

Getting Myozyme (alglucosidase alfa) covered by Blue Cross Blue Shield in Pennsylvania requires prior authorization with confirmed Pompe disease diagnosis via genetic testing and enzyme activity levels. Start today by: (1) calling your specific Blue plan (Highmark or Independence Blue Cross) to request the current PA form, (2) gathering genetic test results showing GAA gene mutations and enzyme deficiency, and (3) having your specialist prepare a medical necessity letter. If denied, Pennsylvania's new external review program overturns about 50% of specialty drug denials within 45 days.

Table of Contents

  1. Start Here: Verify Your Plan and Find Forms
  2. Prior Authorization Forms and Requirements
  3. Submission Portals and Upload Instructions
  4. Fax and Mail Submission Details
  5. Specialty Pharmacy Network Setup
  6. Support Lines and Contact Information
  7. Pennsylvania External Review Process
  8. Common Denial Reasons and Solutions
  9. Medical Necessity Letter Requirements
  10. Appeals Timeline and Strategy

Start Here: Verify Your Plan and Find Forms

Pennsylvania has two major Blue Cross Blue Shield plans with different processes:

Independence Blue Cross (IBX) - Serves southeastern Pennsylvania including Philadelphia

Highmark Blue Cross Blue Shield - Serves western and central Pennsylvania

Tip: Check your insurance card for the specific Blue plan name, as requirements and forms differ between IBX and Highmark.

Coverage at a Glance

Requirement Details Where to Find
Prior Authorization Required for all Blue plans Member portal or call member services
Formulary Tier Tier 5 (Specialty) - 25-30% coinsurance Plan formulary document
Diagnosis Requirement Confirmed Pompe disease via genetic testing Medical records from specialist
Specialist Requirement Neurologist or metabolic disease specialist Provider directory
Appeal Deadline 60 days internal, 4 months external Pennsylvania Insurance Department

Prior Authorization Forms and Requirements

Required Documentation Checklist

Before starting your PA request, gather these essential documents:

  • Insurance card with member ID and group number
  • Genetic test results showing GAA gene mutations
  • Enzyme activity test results (<1% for infantile-onset, <40% for late-onset)
  • Specialist consultation notes from neurologist or metabolic specialist
  • Pulmonary function tests or 6-minute walk test results
  • Prior therapy documentation if applicable

Myozyme-Specific Clinical Criteria

Your physician's PA request must demonstrate:

  1. Confirmed Pompe disease diagnosis with genetic testing showing two pathogenic GAA gene mutations
  2. Enzyme deficiency documented through laboratory testing
  3. Functional impairment evidenced by muscle weakness, respiratory dysfunction, or cardiac involvement
  4. Ability to ambulate at least 40 meters in six-minute walk test (assistive devices permitted)
  5. Not ventilator dependent for continued approvals

Submission Portals and Upload Instructions

Independence Blue Cross (IBX)

  • Provider portal: Log in through IBX provider site
  • Required account: NPI-based provider registration
  • Upload requirements: PDF format, maximum 10MB per file
  • Supporting documents: Upload medical records, lab results, and specialist notes in separate files

Highmark Blue Cross Blue Shield

  • Provider portal: Access through Highmark provider hub
  • Submission method: Electronic PA submission preferred
  • Processing time: 1-3 business days for complete submissions
  • Status tracking: Available through provider portal dashboard
Note: Incomplete submissions trigger automatic denials. Ensure all required clinical documentation is included in your initial request.

Specialty Pharmacy Network Setup

Both IBX and Highmark use CVS Caremark for specialty pharmacy benefits, with Accredo as a primary distributor for Myozyme.

Enrollment Steps

  1. Obtain PA approval from your Blue Cross Blue Shield plan
  2. Contact Accredo at 1-800-803-2523 for enrollment
  3. Complete patient intake including insurance verification
  4. Schedule delivery and nursing education if needed
  5. Set up refill coordination with your prescribing physician

Network Verification

Support Lines and Contact Information

Member Services

  • Independence Blue Cross: 1-800-ASK-BLUE (1-800-275-2583)
  • Highmark BCBS: Number on back of member ID card
  • Best times to call: Weekday mornings, avoid Monday mornings and month-end

Provider Support

  • IBX Provider Services: Available through provider portal
  • Highmark Provider Services: 1-866-731-8080
  • CVS Caremark Prior Authorization: 1-800-294-5979

What to Ask When You Call

  • "What is the current PA form for Myozyme alglucosidase alfa?"
  • "What clinical criteria must be met for approval?"
  • "Can you send me the denial letter if my request was rejected?"
  • "What is the timeline for PA decisions?"

Pennsylvania External Review Process

Pennsylvania launched its Independent External Review Program in January 2024, providing a state-supervised appeals process with a 53% overturn rate for patients.

Eligibility Requirements

  • Must complete internal appeal process first
  • Receive Final Adverse Benefit Determination letter from insurer
  • File within 4 months of final denial letter

Filing Process

  1. Submit online: pa.gov/reviewmyclaim
  2. Call for assistance: 1-877-881-6388 (Pennsylvania Insurance Department)
  3. Include documentation: Medical records, provider letters, denial notices, treatment history

Timeline and Decisions

  • Standard review: 45 days from IRO assignment
  • Expedited review: 72 hours for urgent health threats
  • Additional information: 15 days after assignment to submit supporting documents
  • Binding decision: Insurers must cover overturned denials immediately

Common Denial Reasons and Solutions

Denial Reason Solution Strategy
Insufficient diagnostic documentation Submit complete genetic testing and enzyme activity results
Lack of specialist involvement Obtain consultation from neurologist or metabolic disease specialist
Missing functional assessments Include pulmonary function tests and 6-minute walk test results
Ventilator dependency Document current respiratory status and independence
Incomplete prior therapy documentation Provide detailed history of previous treatments and outcomes

Medical Necessity Letter Requirements

Your specialist's medical necessity letter should address these key elements:

Essential Components

  • Patient identification and confirmed Pompe disease diagnosis
  • Genetic testing results showing specific GAA gene mutations
  • Enzyme activity levels with laboratory reference ranges
  • Clinical presentation including muscle weakness, respiratory symptoms
  • Functional assessment results (6-minute walk test, pulmonary function)
  • Treatment rationale explaining why Myozyme is medically necessary
  • Monitoring plan for treatment response and safety

Supporting Evidence

Include citations to:

  • FDA prescribing information for Myozyme
  • Peer-reviewed studies on enzyme replacement therapy effectiveness
  • Professional society guidelines for Pompe disease management

Appeals Timeline and Strategy

Internal Appeal Process

  • Deadline: 60 days from initial denial
  • Expedited option: Request 72-hour review for urgent situations
  • Required documents: Appeal form, denial letter, additional medical evidence
  • Decision timeline: 30 days for standard, 72 hours for expedited

External Review Strategy

If your internal appeal is denied, Pennsylvania's external review offers strong success rates for specialty drugs:

  1. File promptly: Within 4 months of final denial letter
  2. Submit comprehensive evidence: Include all medical records, specialist letters, and research citations
  3. Request expedited review if treatment delay poses health risks
  4. Follow up: Contact Pennsylvania Insurance Department if timelines are missed
From our advocates: We've seen the strongest success when patients work with their specialists to submit complete documentation upfront rather than responding to requests piece by piece. One patient's Myozyme approval was initially denied for "insufficient diagnostic evidence," but when their neurologist resubmitted with comprehensive genetic testing results and detailed functional assessments, the PA was approved within 48 hours.

When to Contact Pennsylvania Regulators

Contact the Pennsylvania Insurance Department at 1-877-881-6388 if:

  • Your insurer misses appeal deadlines
  • PA requests are repeatedly denied without clear reasoning
  • You need guidance on the external review process
  • Your insurer fails to cover an overturned denial

Counterforce Health helps patients navigate complex prior authorization and appeals processes for specialty medications like Myozyme. Our platform analyzes denial letters and insurance policies to create targeted, evidence-backed appeals that align with each payer's specific requirements. By automating the identification of denial reasons and generating point-by-point rebuttals with appropriate clinical citations, Counterforce Health helps reduce the time and complexity involved in getting life-saving treatments approved.

FAQ

Q: How long does Blue Cross Blue Shield PA take in Pennsylvania? A: Standard PA decisions are made within 1-3 business days for complete electronic submissions. Expedited requests are processed within 24-72 hours.

Q: What if Myozyme is non-formulary on my plan? A: You can request a formulary exception by demonstrating medical necessity and providing evidence that formulary alternatives are inappropriate.

Q: Can I request an expedited appeal in Pennsylvania? A: Yes, both internal appeals and external reviews can be expedited if treatment delay would jeopardize your health. Include physician documentation supporting urgency.

Q: Does step therapy apply to Myozyme? A: Step therapy requirements vary by plan. Your physician can request an exception if you've failed prior therapies or have contraindications.

Q: What happens if I pay out-of-pocket during an appeal? A: If your appeal is successful, insurers must provide retroactive coverage for medications purchased during the appeals process.

Sources & Further Reading

This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For additional help with insurance appeals in Pennsylvania, contact the Pennsylvania Insurance Department at 1-877-881-6388.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.